Teligent, Inc. to Hold Conference Call for Third Quarter 2019 Results on Monday November 4th, 2019
October 31, 2019 16:30 ET
|
Teligent, Inc.
BUENA, N.J., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 4:30pm ET on...
Teligent Announces the Pricing of $34.4 Million of Series B Senior Convertible Notes
October 28, 2019 23:46 ET
|
Teligent, Inc.
BUENA, N.J., Oct. 28, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the pricing of...
Teligent Announces First Injectable Filing From New Manufacturing Facility
October 28, 2019 14:16 ET
|
Teligent, Inc.
BUENA, N.J., Oct. 28, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced that it has filed a prior approval...
Teligent, Inc. Announces FDA Approval of Gentamicin Sulfate Cream USP, 0.1% (Gentamicin Base)
October 18, 2019 15:02 ET
|
Teligent, Inc.
BUENA, N.J., Oct. 18, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
Teligent Announces Strategic Review
October 01, 2019 16:15 ET
|
Teligent, Inc.
BUENA, N.J., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Teligent Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced that it has retained SVB Leerink as its...
Teligent, Inc. Announces Second Quarter 2019 Results
August 05, 2019 16:15 ET
|
Teligent, Inc.
BUENA, N.J., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second...
Teligent, Inc. to Hold Conference Call for Second Quarter 2019 Results on Monday August 5th, 2019
August 01, 2019 11:30 ET
|
Teligent, Inc.
BUENA, N.J., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm...
Teligent, Inc. to Present at the Raymond James Life Sciences and MedTech Conference on June 19th 2019
June 18, 2019 16:27 ET
|
Teligent, Inc.
BUENA, N.J., June 18, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Raymond James Life Sciences and...
Teligent, Inc. to Present at the Raymond James Life Sciences and MedTech Conference on June 19th 2019
June 18, 2019 11:30 ET
|
Teligent, Inc.
BUENA, N.J., June 18, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Raymond James Life Sciences and...
Teligent, Inc. Announces First Quarter 2019 Results
May 06, 2019 16:15 ET
|
Teligent, Inc.
BUENA, N.J., May 06, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the first quarter...